Chrissy Teigen - author, entrepreneur, mom to young son with type 1 diabetes - joins Sanofi's Screen For Type 1 movement
Sanofi (SNY) has announced that Chrissy Teigen has joined as the new celebrity spokesperson for their Screen For Type 1 movement. The partnership, revealed on T1D Day, aims to promote early type 1 diabetes risk detection through screening.
Teigen's involvement stems from her personal experience with her son Miles, who was diagnosed with type 1 diabetes at age six in 2024 after an unexpected medical emergency. This reflects a common scenario, as approximately 64,000 Americans are diagnosed annually with type 1 diabetes, with up to 40% unaware of their condition until experiencing life-threatening complications.
The Screen For Type 1 initiative emphasizes that the disease can be detected through a single blood test that identifies diabetes-related autoantibodies before symptoms appear. While type 1 diabetes cannot be prevented, early detection can help families better prepare and plan for managing the condition.
Sanofi (SNY) ha annunciato che Chrissy Teigen è la nuova testimonial celebre per il loro movimento Screen For Type 1. La collaborazione, svelata in occasione della Giornata del T1D, mira a promuovere la diagnosi precoce del rischio di diabete di tipo 1 attraverso lo screening.
Il coinvolgimento di Teigen nasce dalla sua esperienza personale con il figlio Miles, a cui è stato diagnosticato il diabete di tipo 1 all'età di sei anni nel 2024, dopo un'emergenza medica improvvisa. Questa situazione è comune, poiché circa 64.000 americani ricevono ogni anno la diagnosi di diabete di tipo 1, e fino al 40% di loro non è consapevole della propria condizione fino a quando non si manifestano complicazioni potenzialmente letali.
L'iniziativa Screen For Type 1 sottolinea che la malattia può essere individuata con un semplice esame del sangue che rileva gli autoanticorpi legati al diabete prima della comparsa dei sintomi. Sebbene il diabete di tipo 1 non possa essere prevenuto, una diagnosi precoce aiuta le famiglie a prepararsi e organizzarsi meglio per la gestione della malattia.
Sanofi (SNY) ha anunciado que Chrissy Teigen se ha unido como la nueva portavoz famosa de su movimiento Screen For Type 1. La colaboración, revelada en el Día del T1D, tiene como objetivo promover la detección temprana del riesgo de diabetes tipo 1 mediante el cribado.
La participación de Teigen surge de su experiencia personal con su hijo Miles, quien fue diagnosticado con diabetes tipo 1 a los seis años en 2024 tras una emergencia médica inesperada. Esto refleja una situación común, ya que aproximadamente 64,000 estadounidenses son diagnosticados anualmente con diabetes tipo 1, y hasta un 40% desconoce su condición hasta experimentar complicaciones potencialmente mortales.
La iniciativa Screen For Type 1 enfatiza que la enfermedad puede detectarse mediante un simple análisis de sangre que identifica autoanticuerpos relacionados con la diabetes antes de que aparezcan los síntomas. Aunque la diabetes tipo 1 no se puede prevenir, la detección temprana ayuda a las familias a prepararse y planificar mejor el manejo de la enfermedad.
사노피(SNY)가 크리시 타이겐을 Screen For Type 1 캠페인의 새로운 유명인 홍보대사로 임명했다고 발표했습니다. 이 파트너십은 T1D의 날에 공개되었으며, 조기 제1형 당뇨병 위험 감지를 위한 검진을 촉진하는 것을 목표로 합니다.
타이겐의 참여는 2024년 여섯 살 때 예상치 못한 의료 응급 상황으로 제1형 당뇨병 진단을 받은 아들 마일스의 개인적인 경험에서 비롯되었습니다. 이는 흔한 상황으로, 매년 약 64,000명의 미국인이 제1형 당뇨병 진단을 받으며, 이 중 최대 40%는 생명을 위협하는 합병증이 나타날 때까지 자신의 상태를 모르는 경우가 많습니다.
Screen For Type 1 이니셔티브는 증상이 나타나기 전에 당뇨병 관련 자가항체를 확인하는 단일 혈액 검사로 질병을 발견할 수 있음을 강조합니다. 제1형 당뇨병은 예방할 수 없지만, 조기 발견은 가족들이 질병 관리에 더 잘 대비하고 계획할 수 있도록 돕습니다.
Sanofi (SNY) a annoncé que Chrissy Teigen rejoint leur mouvement Screen For Type 1 en tant que nouvelle ambassadrice célèbre. Ce partenariat, révélé lors de la Journée T1D, vise à promouvoir la détection précoce du risque de diabète de type 1 grâce au dépistage.
L'engagement de Teigen découle de son expérience personnelle avec son fils Miles, diagnostiqué avec un diabète de type 1 à l'âge de six ans en 2024, suite à une urgence médicale inattendue. Cela reflète une situation courante, puisque environ 64 000 Américains sont diagnostiqués chaque année avec un diabète de type 1, dont jusqu'à 40% ignorent leur état jusqu'à ce qu'ils subissent des complications potentiellement mortelles.
L’initiative Screen For Type 1 souligne que la maladie peut être détectée par un simple test sanguin identifiant les auto-anticorps liés au diabète avant l’apparition des symptômes. Bien que le diabète de type 1 ne puisse pas être prévenu, une détection précoce aide les familles à mieux se préparer et à planifier la gestion de la maladie.
Sanofi (SNY) hat bekanntgegeben, dass Chrissy Teigen als neue prominente Botschafterin für ihre Screen For Type 1-Initiative gewonnen wurde. Die Partnerschaft, die am T1D-Tag vorgestellt wurde, zielt darauf ab, die Früherkennung des Risikos für Typ-1-Diabetes durch Screening zu fördern.
Teigens Engagement basiert auf ihrer persönlichen Erfahrung mit ihrem Sohn Miles, bei dem 2024 im Alter von sechs Jahren nach einem unerwarteten medizinischen Notfall Typ-1-Diabetes diagnostiziert wurde. Dies ist ein häufiges Szenario, da jährlich etwa 64.000 Amerikaner mit Typ-1-Diabetes diagnostiziert werden, wobei bis zu 40% ihre Erkrankung erst erkennen, wenn lebensbedrohliche Komplikationen auftreten.
Die Screen For Type 1-Initiative betont, dass die Krankheit durch einen einfachen Bluttest erkannt werden kann, der diabetesbezogene Autoantikörper vor dem Auftreten von Symptomen nachweist. Obwohl Typ-1-Diabetes nicht verhindert werden kann, hilft eine frühzeitige Erkennung Familien, sich besser auf die Bewältigung der Erkrankung vorzubereiten und zu planen.
- Partnership with high-profile celebrity spokesperson enhances disease awareness campaign visibility
- Strengthens Sanofi's position in diabetes care market through educational initiative
- None.
- Teigen to advocate for the importance of type 1 diabetes screening after son's diagnosis was uncovered during an unexpected medical emergency
- Screen For Type 1 movement continues momentum into year two with the goal of encouraging people to screen early; just one blood test can spot type 1 diabetes before symptoms occur
Teigen has a personal connection to type 1 diabetes. Her son, Miles, was diagnosed unexpectedly at the age of six and ended up in the hospital due to complications from the disease – an experience shared by many individuals and families. In fact, each year, around 64,000 Americans are diagnosed with type 1 diabetes; as many as
Chrissy Teigen
Author, entrepreneur, and mom
"Our family knew nothing about type 1 diabetes prior to 2024 – and when I say nothing, I mean absolutely nothing. We were confused and scared when Miles was first diagnosed. Miles is a warrior – a type 1 diabetes warrior – and we are learning together every day how to help him manage this disease, but there is no doubt in my mind that knowing in advance would have made a positive impact for Miles, me, and our entire family. I want everyone to hear me when I say: stay proactive and talk to your doctor about getting yourself or your loved ones screened for type 1 diabetes today!"
Nadia Fontaine
Head, US Autoimmune Type 1 Diabetes Franchise
"It's unacceptable that many people are still finding out about a type 1 diabetes diagnosis only when serious complications arise. We're energized to partner with Chrissy Teigen on the Screen For Type 1 movement and believe her story will strongly resonate with families and underscore the importance of early risk detection."
Anyone can screen for type 1 diabetes, which consists of just one blood test that identifies whether a person has autoantibodies related to type 1 diabetes before symptoms even appear. While type 1 diabetes cannot be prevented, it can be detected early through autoantibody screening, before serious health complications may occur, which may give people more time to prepare and plan for the future.
People can visit ScreenForType1.com for helpful tools and resources about early screening options. Sanofi encourages people interested in learning more about screening for type 1 diabetes to speak to their doctor.
Teigen and other social media personalities who are participating in the Screen For Type 1 movement are paid spokespeople for Sanofi.
About Sanofi
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people's lives. Our team, across the world, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY
Media Relations
Evan Berland | + 1 215 432 0234 | evan.berland@sanofi.com
Investor Relations
Thomas Kudsk Larsen |+44 7545 513 693 | thomas.larsen@sanofi.com
Alizé Kaisserian | +33 6 47 04 12 11 | alize.kaisserian@sanofi.com
Felix Lauscher | +1 908 612 7239 | felix.lauscher@sanofi.com
Keita Browne | +1 781 249 1766 | keita.browne@sanofi.com
Nathalie Pham | +33 7 85 93 30 17 | nathalie.pham@sanofi.com
Tarik Elgoutni | +1 617 710 3587 | tarik.elgoutni@sanofi.com
Thibaud Châtelet | +33 6 80 80 89 90 | thibaud.chatelet@sanofi.com
Yun Li | +33 6 84 00 90 72 | yun.li3@sanofi.com
Sanofi Forward-Looking Statements
This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates regarding the marketing and other potential of the product, or regarding potential future revenues from the product. Forward-looking statements are generally identified by the words "expects", "anticipates", "believes", "intends", "estimates", "plans", and similar expressions. Although Sanofi's management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Sanofi, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, unexpected regulatory actions or delays, or government regulation generally, that could affect the availability or commercial potential of the product, the fact that product may not be commercially successful, the uncertainties inherent in research and development, including future clinical data and analysis of existing clinical data relating to the product, including post marketing, unexpected safety, quality or manufacturing issues, competition in general, risks associated with intellectual property and any related future litigation and the ultimate outcome of such litigation, and volatile economic and market conditions, and the impact that global crises may have on us, our customers, suppliers, vendors, and other business partners, and the financial condition of any one of them, as well as on our employees and on the global economy as a whole. The risks and uncertainties also include the uncertainties discussed or identified in the public filings with the SEC and the AMF made by Sanofi, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in Sanofi's annual report on Form 20-F for the year ended December 31, 2024. Other than as required by applicable law, Sanofi does not undertake any obligation to update or revise any forward-looking information or statements.
All trademarks mentioned in this press release are the property of the Sanofi group.
View original content:https://www.prnewswire.com/news-releases/chrissy-teigen--author-entrepreneur-mom-to-young-son-with-type-1-diabetes--joins-sanofis-screen-for-type-1-movement-302426703.html
SOURCE Sanofi
FAQ
What is Sanofi's Screen For Type 1 movement and who is their new spokesperson?
How many Americans are diagnosed with type 1 diabetes annually according to SNY?
What type of screening test does Sanofi's program recommend for type 1 diabetes?
When was Chrissy Teigen's son diagnosed with type 1 diabetes?
